Prevalence of transthyretin and immunoglobulin light chain cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement

Back

ESC Premium Access

Prevalence of transthyretin and immunoglobulin light chain cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement

Session: Poster Session 2 - Transcatheter valve intervention in the real world

Topic: Aortic Valve Intervention

Speaker: Doctor C. Nitsche (Vienna, AT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Christian Nitsche

Medical University of Vienna, Vienna (Austria)

2 presentations

2 followers

9 more presentations in this session

Impact of left ventricular outflow tract sphericity on transcatheter heart valve hemodynamics and outcome after transcatheter aortic valve implantation

Speaker: Doctor E. Holy (Zurich, CH)

Access

Abstract

Transcatheter aortic valve implantation in patients with uninterrupted vitamin k antagonist

Speaker: Doctor P. Robert (Nimes, FR)

Access

Abstract

Slides

Blood erythropoietin independently predicts mid-term survival after post-procedural recovery from transcatheter aortic valve replacement in aortic stenosis: a prospective study

Speaker: Doctor S. Mas-Peiro (Frankfurt, DE)

Access

Abstract

11 years of transcatheter aortic valve implantation in a single centre and outcomes for all 1004 patient cases completed.

Speaker: Doctor P. Brennan (Belfast, GB)

Access

Abstract

Slides

Comparing outcomes and complications between transfemoral TAVI performed with or without echoguided puncture.

Speaker: Mr J. Bouteau (Tours, FR)

Access

Abstract

Slides

Access the full session

Poster Session 2 - Transcatheter valve intervention in the real world

Speakers: Doctor C. Nitsche, Doctor E. Holy, Doctor P. Robert, Doctor S. Mas-Peiro, Doctor P. Brennan...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources